Chronic Kidney Disease affecting the Characteristics of Blood Pressure: An Observational Study
Abstract
Background: Chronic kidney disease (CKD) is a global public-health problem that affects millions of individuals. Despite widespread use of medicines to slow the course of CKD, the burden of end-stage renal disease in many affluent nations remains high. Hypertension is far more frequent in persons with CKD than it is in the general population, and it becomes worse as renal function declines. Controlling blood pressure, which is a controllable risk factor for this complication, may reduce the risk of cardiovascular events and decrease the decline of renal function.
Objective: To asses the Characteristics of Blood Pressure in Chronic Kidney Disease.
Materials and Methods: A cross-sectional Study was conducted at MS Ramaiah Medical College, Bangalore from 1st of January 2018 to 31st of July 2019. A total of 100 Cases were included in the study.
Results: In our research, 10% of the participants were under the age of 30. In the research, 33% of the participants had Stage 3 CKD, 35% had Stage 4 CKD, and 32% had Stage 5 CKD. There was a significant
difference in mean OSBP and mean ODBP with increasing CKD stage in the research. With rising CKD stage, mean OSBP and ODBP increased.
Conclusion: Ambulatory BP measurements revealed a significant degree of overestimation (white coat HTN) and underestimate (masked HTN) of BP among patients with CKD, indicating that adopting ABPM may
assist avoid mistakes in BP measurement as well as correct treatment of HTN in CKD.
How to cite this article:
Abhishek KB, Sumanth BV, Ramesh B. Chronic Kidney Disease affecting the Characteristics of Blood Pressure: An Observational Study. J Adv Res Med. 2021;8(3):22-26.
DOI: https://doi.org/10.24321/2349.7181.202116
References
Portaluppi F, Boari B, Manfredini R. Oxidative stress in essential hypertension. Curr Pharm Des. 2004;10:1695-
[PubMed] [Google Scholar]
Stenvinkel P. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular
disease. J Intern Med. 2010;268:456-467. [PubMed] [Google Scholar]
Drawz PE, Abdalla M, Rahman M. Blood pressure measurement: clinic, home, ambulatory, and beyond.
Am J Kidney Dis. 2012; 60:449-462. [PubMed] [Google Scholar]
Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney
disease in the United States. JAMA. 2007; 298:2038-47. [PubMed] [Google Scholar]
Sarafidis PA, Li S, Chen SC, Collins AJ, Brown WW, Klag MJ, Bakris GL. Hypertension awareness, treatment,
and control in chronic kidney disease. Am J Med. 2008;121:332-340. [PubMed] [Google Scholar]
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation,
classification, and stratification. Am J Kidney Dis. 2002; 39:S1-S266. [PubMed]
Agarwal R, Nissenson AR, Battle D, Coyne DW, Trout JR, Warnock DG. Prevalence, treatment, and control
of hypertension in chronic hemodialysis patients in the United States. Am J Med. 2003;115:291-297.
[PubMed] [Google Scholar]
Gorostidi M, Sarafidis PA, de la Sierra A, Segura J, de la Cruz JJ, Banegas JR, Ruilope LM, Spanish AB. Spanish
ABPM Registry Investigators. Differences between office and 24-hour blood pressure control in hypertensive
patients with CKD: a 5,693-patient cross-sectional analysis from Spain. Am J Kidney Dis. 2013;62:285-94.
[PubMed] [Google Scholar]
Pogue V, Rahman M, Lipkowitz M, Toto R, Miller E, Faulkner M, Rostand S, Hiremath L, Sika M, Kendrick C,
Hu B, Greene T, Appel L, Phillips RA. African American Study of Kidney Disease and Hypertension Collaborative
Research Group: disparate estimates of hypertension control from ambulatory and clinic blood pressure
measurements in hypertensive kidney disease. Hypertension. 2009;53:20-27. [PubMed] [Google
Scholar]
Sarafidis PA, Khosla N, Bakris GL. Antihypertensive therapy in the presence of proteinuria. Am J Kidney
Dis. 2007;49:12-26. [PubMed] [Google Scholar]
Muntner P, Anderson A, Charleston J, Chen Z, Ford V, Makos G, O’Connor A, Perumal K, Rahman
M, Steigerwalt S, Teal V. Hypertension awareness, treatment, and control in adults with CKD: results
from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2010;55:441-51. [PubMed]
[Google Scholar]
Kidney Disease Improving Global Outcome (KDIGO). KDIGO 2012 clinical practice guideline for the evaluation
and management of chronic kidney disease. Kidney Int Suppl. 2013; 3: 1-150.
Gorostidi M, Sarafidis P, Sieraa A, Banegas J, De La Curz, Vinyoles E. Differences between office and 24
hrs blood pressure control in hypertensive patients with CKD: A 5693 patient cross sectional analysis from
Spain. Am J Kid Dis. 2013;62(2):285-294. [PubMed] [Google Scholar]
Cunha C, Pereira S, Fernandes JC, Dias VP.. 24-hour ambulatory blood pressure monitoring in chronic
kidney disease and its influence on treatment. Chinese General Practice. 2017;29(1):161-169. [Google Scholar]
Prakash S, Chibber SK, Prakash S, Pande DP, Joshi S, Gupta KK, Rana DS.Assessment of hypertension control
in chronic kidney disease patients by ambulatory blood pressure monitoring. JAPI. 2005;53(1):769-74. [Google
Scholar]
Singh AK, Farag YM, Mittal BV, Subramanian KK, Reddy SR, Acharya VN, Almeida AF, Channakeshavamurthy A,
Ballal HS, Gaccione P, Issacs R. Epidemiology and risk factors of chronic kidney disease in India - results from
the SEEK (screening and early evaluation of kidney disease) study. BMC Nephrol. 2013;14(1):114. [Google
Scholar]
Iimuro S, Imai E, Watanabe T, Nitta K, Akizawa T, Matsuo S, Makino H, Ohashi Y, Hishida A, Clinical Correlates of Ambulatory BP Monitoring among Patients with CKD. Clin J Am Soc Nephrol. 2013;8(5):721-730. [PubMed]
[Google Scholar]
Oh YK, Chin HJ, Ahn SY, An JN, Lee JP, Lim CS, Oh KH. Discrepancies in clinic and Ambulatory Blood Pressure
in Korean Chronic Kidney Disease Patients. Journal of Korean Medical Sciences. 2017;32(5):772-781.
[PubMed] [Google Scholar]
Pogue V, Rahman M, Lipkowitz M, Toto R, Miller E, Faulkner M, Rostand S, Hiremath L, Sika M, Kendrick C,
Hu B. Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements
in hypertensive kidney disease. Hypertension. 2009;53(1):20-27. [PubMed] [Google Scholar]
Otero A, Dominguez Sardina M, Castineria M, Crespo J, Ferras A, Mojon A . Alteration of the Circadian
Blood Pressure Pattern in Subjects with Chronic Kidney Disease: The HYGIA Project. J Hypertension.
;29:e174. [Google Scholar]
Copyright (c) 2021 Abhishek KB, Sumanth BV, Ramesh B
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
